TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

Clinical trial NCT07487363 · RECRUITING

Trial details

NCT number: NCT07487363
Sponsor: Hudson Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Diseases Endothelial Dysfunction

Start date: 2026-02-05
Primary completion: 2027-02-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.